王
王宁 Directeur, Dirigeant
Other
FR FR · AMF
Browse the detailed record of transactions filed by 王宁, Directeur, Dirigeant. Director active across 2 companies, notably 神州泰岳. Aggregated, 65 disclosures have been logged. Regulator: AMF. All data is free.
Declarations 65 total
100,000 shares
SSE:273000000264513020 · 19 Mar 2026
Executives ● Sale神 神州泰岳 10 SZSE 4,590,000 shares
SZSE:173000008409332830 · 7 Jan 2025
Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005689829440 · 15 Jul 2022
Ideal exit: 11 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005681551840 · 14 Jul 2022
Ideal exit: 10 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 150,000 shares
SZSE:173000005649177630 · 1 Jul 2022
Ideal exit: 28 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 54,700 shares
SZSE:173000005641036200 · 30 Jun 2022
Ideal exit: 27 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 114,400 shares
SZSE:173000005614950050 · 23 Jun 2022
Ideal exit: 20 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 200,000 shares
SZSE:173000005610978700 · 21 Jun 2022
Ideal exit: 18 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 150,000 shares
SZSE:173000005605692350 · 17 Jun 2022
Ideal exit: 14 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 99,500 shares
SZSE:173000005599321340 · 16 Jun 2022
Ideal exit: 13 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 15,000 shares
SZSE:173000005595967330 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005585460670 · 10 Jun 2022
Ideal exit: 7 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005581163970 · 9 Jun 2022
Ideal exit: 6 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005578660200 · 8 Jun 2022
Ideal exit: 5 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005564436580 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 100,600 shares
SZSE:173000005564436540 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005560793300 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 3,000 shares
SZSE:173000005555753570 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005552239070 · 26 May 2022
Ideal exit: 20 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 4,000 shares
SZSE:173000005547832130 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005545391140 · 23 May 2022
Ideal exit: 17 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005542928000 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005522950560 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005503421700 · 29 Apr 2022
Ideal exit: 24 Jan 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005491228640 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) 25 of 65 declarations
Load more (40 remaining) About 王宁 Wang Ning is a director and executive at Shenzhou Taiyue and Juran Zhijia, where he oversees operations and the company's strategy. With experience in the sector, he is committed to improving operational efficiency and strengthening the company's market position. Wang is recognized for his leadership and ability to inspire his teams.